Empagliflozin Attenuates Cardiac and Peritoneal Injury in a Cardiovascular-Kidney-Metabolic Syndrome Model with Peritoneal Dialysis

J.A. Kane; M. Karsten; A.S. van Bergen; E. Lutgens; C.E. van den Brom; Marc Vervloet; E.C. Eringa; Jakulj  L

Empagliflozin Attenuates Cardiac and Peritoneal Injury in a Cardiovascular-Kidney-Metabolic Syndrome Model with Peritoneal Dialysis

J.A. Kane
, M. Karsten
, A.S. van Bergen
, E. Lutgens
, C.E. van den Brom
, Marc Vervloet
, E.C. Eringa
, Jakulj L

Department of Cardiovascular Medicine and Immunology, Mayo Clinic, Rochester, Minnesota, the United States
464 Department of Nephrology, Radboud University Medical Center, PO box 9101, 6500 HB, Nijmegen, The Netherlands.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Journal	Kidney International Reports
Publication status	Submitted - 1 Jun 2026

Cite this

@article{6ca491d785cb4ae49333c18e75c08d8d,

title = "Empagliflozin Attenuates Cardiac and Peritoneal Injury in a Cardiovascular-Kidney-Metabolic Syndrome Model with Peritoneal Dialysis",

author = "J.A. Kane and M. Karsten and \{van Bergen\}, A.S. and E. Lutgens and \{van den Brom\}, C.E. and Marc Vervloet and E.C. Eringa and Jakulj L",

year = "2026",

month = jun,

day = "1",

language = "English",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Empagliflozin Attenuates Cardiac and Peritoneal Injury in a Cardiovascular-Kidney-Metabolic Syndrome Model with Peritoneal Dialysis

AU - Kane, J.A.

AU - Karsten, M.

AU - van Bergen, A.S.

AU - Lutgens, E.

AU - van den Brom, C.E.

AU - Vervloet, Marc

AU - Eringa, E.C.

AU - L, Jakulj

PY - 2026/6/1

Y1 - 2026/6/1

M3 - Article

SN - 2468-0249

JO - Kidney International Reports

JF - Kidney International Reports

ER -